Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Nordea Bank AB (publ) (“Nordea”) in connection with a tender offer and issue of new bonds with an aggregate transaction value of SEK 2,705,000,000
Mandate

Vinge has advised Nordea Bank AB (publ) (“Nordea”) in connection with a tender offer and issue of new bonds with an aggregate transaction value of SEK 2,705,000,000

October 03, 2018 Banking and Finance

Vinge has advised Nordea Bank AB (publ) (“Nordea”) in connection with a tender offer and issue of new bonds with an aggregate transaction value of SEK 2,705,000,000.

Vinge has advised Nordea in connection with Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) tender offer and subsequent repurchase of its previously issued senior and unsecured bonds up to a total amount of SEK 1,205,000,000 (the “Tender Offer”) and its issuance of new senior unsecured bonds with a framework amount of up to SEK 1,500,000,000 (the “New Bonds”).

The initial amount issued under the New Bonds amounts to SEK 1,000,000,000 per 3 October 2018. Nordea was mandated as sole arranger, bookrunner and issuing agent in connection with the New Bonds and as dealer manager, sole bookrunner and tender agent in relation to the Tender Offer.

The New Bonds have a tenor of four years and carry a floating rate interest of STIBOR 3M + 3.60%.

Vinge’s team consisted of Mikael Ståhl, Josefine Larsson and Lionardo Ojeda.

Related

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025

Vinge advises Advania in connection with the acquisition of atNorth HPC AB

Vinge has advised Advania, one of the leading IT companies in the Nordic region, in connection with the acquisition of atNorth HPC AB. The acquisition strengthens Advania's presence within high-performance computing (HPC).
October 03, 2025